Bayesian Approaches in Drug Development: Interpreting the 2026 US Food and Drug Administration Draft Guidance for Optimal Dose Finding

Ayon Mukherjee
Pharmaceutical Statistics · Wiley · 2026-11-13 · DOI: 10.1002/pst.70149

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles